Research Article

Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation

Table 1

HPLC-UV gradient programme for analysis of informal stability samples.

Time (minutes)Mobile phase A (%)Mobile phase B (%)

01000
10973
258020
356535
456040
461000
501000